384 related articles for article (PubMed ID: 22821910)
1. Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.
Moore JR; Leinwand L; Warshaw DM
Circ Res; 2012 Jul; 111(3):375-85. PubMed ID: 22821910
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
3. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
[TBL] [Abstract][Full Text] [Related]
4. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
Xu Q; Dewey S; Nguyen S; Gomes AV
J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
[TBL] [Abstract][Full Text] [Related]
5. Molecular etiology and pathogenesis of hereditary cardiomyopathy.
Kimura A
Circ J; 2008; 72 Suppl A():A38-48. PubMed ID: 18772524
[TBL] [Abstract][Full Text] [Related]
6. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
[TBL] [Abstract][Full Text] [Related]
7. Sarcomeric proteins and inherited cardiomyopathies.
Morimoto S
Cardiovasc Res; 2008 Mar; 77(4):659-66. PubMed ID: 18056765
[TBL] [Abstract][Full Text] [Related]
8. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O; Leinwand LA
Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
[TBL] [Abstract][Full Text] [Related]
10. Targeting the sarcomere in inherited cardiomyopathies.
Lehman SJ; Crocini C; Leinwand LA
Nat Rev Cardiol; 2022 Jun; 19(6):353-363. PubMed ID: 35304599
[TBL] [Abstract][Full Text] [Related]
11. Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.
Yadav S; Sitbon YH; Kazmierczak K; Szczesna-Cordary D
Pflugers Arch; 2019 May; 471(5):683-699. PubMed ID: 30706179
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.
van Waning JI; Caliskan K; Michels M; Schinkel AFL; Hirsch A; Dalinghaus M; Hoedemaekers YM; Wessels MW; IJpma AS; Hofstra RMW; van Slegtenhorst MA; Majoor-Krakauer D
J Am Coll Cardiol; 2019 Apr; 73(13):1601-1611. PubMed ID: 30947911
[TBL] [Abstract][Full Text] [Related]
13. Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.
Deranek AE; Klass MM; Tardiff JC
Pflugers Arch; 2019 May; 471(5):661-671. PubMed ID: 30848350
[TBL] [Abstract][Full Text] [Related]
14. In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament.
Harris SP; Lyons RG; Bezold KL
Circ Res; 2011 Mar; 108(6):751-64. PubMed ID: 21415409
[TBL] [Abstract][Full Text] [Related]
15. Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.
Kawana M; Sarkar SS; Sutton S; Ruppel KM; Spudich JA
Sci Adv; 2017 Feb; 3(2):e1601959. PubMed ID: 28246639
[TBL] [Abstract][Full Text] [Related]
16. Multiscale biophysical models of cardiomyopathies reveal complexities challenging existing dogmas.
Scott B; Greenberg MJ
Biophys J; 2023 Dec; 122(24):4632-4634. PubMed ID: 38006882
[TBL] [Abstract][Full Text] [Related]
17. HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments.
Farman GP; Rynkiewicz MJ; Orzechowski M; Lehman W; Moore JR
Arch Biochem Biophys; 2018 Jun; 647():84-92. PubMed ID: 29626422
[TBL] [Abstract][Full Text] [Related]
18. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.
Vikstrom KL; Factor SM; Leinwand LA
Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms in cardiomyopathy.
Dadson K; Hauck L; Billia F
Clin Sci (Lond); 2017 Jul; 131(13):1375-1392. PubMed ID: 28645928
[TBL] [Abstract][Full Text] [Related]
20. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
